Aptevo Therapeutics Inc.
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.47M | -24.03M | -23.70M | -24.13M | -23.72M |
| Total Depreciation and Amortization | 230.00K | 265.00K | 307.00K | 352.00K | 397.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.00K | 94.00K | 530.00K | 1.07M | 1.50M |
| Change in Net Operating Assets | 106.00K | -983.00K | -842.00K | -1.08M | -1.45M |
| Cash from Operations | -26.12M | -24.65M | -23.71M | -23.79M | -23.28M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 39.42M | 25.99M | 15.60M | 15.60M | 11.93M |
| Repurchase of Common Stock | 0.00 | 0.00 | -1.00K | -1.00K | -3.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | -3.00K | -3.00K |
| Cash from Financing | 39.42M | 25.99M | 15.60M | 15.60M | 11.92M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.31M | 1.34M | -8.11M | -8.19M | -11.36M |